<i>LMX1A</i> and <i>APOE ɛ</i> Genotype Associations With Working Memory Training Effects in HIV and Non-HIV
This study provides Class IV evidence that adaptive WMT improves near-transfer WM, far-transfer performance, and self-reported executive functioning in patients with or without HIV, regardless of <i>LMX1A</i> or <i>APOE ɛ4</i> genotype status. NCT02602418 (registered at ClinicalTrials.gov, Registered: May 11, 2015. First patient enrolled: September 15, 2012.
Authors
- Julian Baptiste
- Jeremy C. Wang (ORCID: https://orcid.org/0000-0002-3721-610X)
- Huajun Liang (ORCID: https://orcid.org/0000-0002-3118-6296)
- Eric Cunningham (ORCID: https://orcid.org/0000-0002-8683-0923)
- Linda Chang (ORCID: https://orcid.org/0000-0002-1267-0699)
- Thomas Ernst (ORCID: https://orcid.org/0000-0003-1211-7655)
- Gro Christine Christensen Løhaugen (ORCID: https://orcid.org/0000-0003-0179-7245)
Institutions
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Sørlandet Hospital Arendal (NO)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1212/nxi.0000000000200519
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00